Sarsia Seed Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 5
- Investments
- 47
- Portfolio
- 15
- Exits
- 13
Sarsia Seed General Information
Description
Sarsia Seed is a seed and early stage venture capital firm based in Bergen, Norway and was founded in 2006. The firm seeks to invest in the energy, clean technology, alternative energy technology, diagnostics, biotechnology and life science sectors.
Contact Information
Website
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Postboks 7150
- 5020 Bergen
- Norway
Sarsia Seed Investments (47)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Heimdall Power | 01-Jul-2020 | Later Stage VC | 00.000 | Energy Infrastructure | Generating Revenue | |
| 000000000 | 06-Mar-2020 | 0000 00000 | 000 | Decision/Risk Analysis | Pre-Clinical Trials | |
| 000000000 | 16-May-2019 | 0000 00000 | 000 | Decision/Risk Analysis | Pre-Clinical Trials | |
| 0000000 | 01-Jul-2018 | 00000 00000 | 00000 | Diagnostic Equipment | Startup | |
| 00000000 | 01-Jan-2018 | 00000 00000 | Wireless Communications Equipment | Generating Revenue | ||
| 00000 | 01-Jan-2018 | 00000 00000 | 00.00 | Electronic Equipment and Instruments | Generating Revenue | 000 0000 |
| 0000 000000000000 | 01-Dec-2017 | 00000 00000 | 000 | Drug Discovery | Pre-Clinical Trials | 000000 00000000 |
| 00000000 00000 | 01-Aug-2017 | 00000 00000 | 00.000 | Energy Infrastructure | Generating Revenue | |
| Pluvia | 24-Mar-2017 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Xsens | 01-Dec-2016 | Seed Round | 00.000 | Electronic Equipment and Instruments | Generating Revenue | 000 0000 |
Sarsia Seed Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Prophylix | 28-Jun-2019 | Merger/Acquisition | |
| 000000000 | 01-Jan-2019 | 000 00 00000000 | |
| 0000000 | 01-Nov-2017 | 000 00 00000000 | |
| 000000000 | 07-Apr-2017 | 000 | 000.00 |
| 000 000000 | 01-May-2016 | 000 00 00000000 | |
| 0000000 | 02-Jul-2015 | 000000000000000000 | |
| 0000000 | 01-Jan-2015 | 000 00 00000000 | |
| 00000000 | 01-May-2012 | 000 00 00000000 | |
| Delante Health | 01-Feb-2012 | Out of Business | |
| Blue Limit | 01-Jun-2009 | Out of Business |
Sarsia Seed Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Sarsia Seed‘s full profile, request access.
Request a free trialSarsia Seed Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSarsia Seed Team (5)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Marit Wick | Partner & Chief Financial Officer | Bergen, Norway | |||
| Erlend Skagseth | Managing Partner | 0 | 0 | 0 | Bergen, Norway |
| Øivind Enger Ph.D | Partner & Investment Advisor | 0 | Bergen, Norway | ||
| Jon Berg | Partner, Energy and Technology | 0 | 0 | 0 | Bergen, Norway |
| Farzad Abdi-Dezfuli | Partner, Life Science Investments | 0 | 0 | 0 | Bergen, Norway |
Sarsia Seed Co-Investors (13)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Investinor | 5 | 0 |
|
|
|
| CoFounder | 0 |
|
|
||
| Sintef Venture | 0 |
|
|
||
| BKK Production | 0 |
|
|
||
| Televenture | 0 | 0 |
|
|